~~<i id='F876D0BD85'><strike id='F876D0BD85'><tt id='F876D0BD85'><pre id='F876D0BD85'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：focus 2025-09-06 04:17:25 - browse：7

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： UnitedHealth, Optum discontinue NaviHealth name

Wikipedia

hotspot

Wikipedia

focus

MARKRALSTON/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toget

WSS

Sanofi strikes deal with Novavax, boosting the vaccine maker

H5N1 bird flu: what we're starting to learn about infection in cows

Study: People of West African ancestry at greater risk of cardiac amyloidosis

How to improve immunocompromised access to mAb treatments

Study: AI not yet building 'n

After gene therapy, two congenitally deaf children hear for the first time

explore

hotspot

Wikipedia

Cancer drug shortages should be causing more outrage

After gene therapy, two congenitally deaf children hear for the first time

Jerome Adams on the need for new antivirals for Covid

STAT Summit: Meghan O’Rourke on making chronic illness visible

Drug repurposing or repositioning? The language matters

Elevance, private equity launch primary care company

How to save PrEP access — and even expand it

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Supreme Court strikes down use of affirmative action

Medicare says breakthrough device reimbursement rule to come by summer

hotspot

What nurses really want: sufficient staffing for patient care

Sanofi strikes deal with Novavax, boosting the vaccine maker

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Medicare says breakthrough device reimbursement rule to come by summer

hotspot

hotspot

Wikipedia

focus